Greenwich LifeSciences Publishes Additional Positive Safety Data from GP2 Phase IIb Trial at ASCO 2021, Confirming that GP2 Treatment to Prevent Metastatic Breast Cancer Recurrence is Well Tolerated | Business Wire
Ocean Genomics Poster - ASCO 2023 with Yale Cancer Center - Identifying Molecular Predictors and Immunomodulatory Role of Dual Checkpoint Inhibitors in Small Cell Lung Cancer - Ocean Genomics
ASCO Quality Care Symposium Poster - Carevive - cancer care management & patient engagement tools
Orano Med presented a poster at 2022 ASCO annual meeting
VBI Vaccines Reports Data from Part A of the Ongoing Phase 1/2a Study of VBI-1901 in Recurrent Glioblastoma (GBM) Patients at ASCO 2019 - VBI Vaccines
American Society of Clinical Oncology (ASCO) 2018 – Poster | Sutro Biopharma, Inc.
ASCO 2020: 8q22 Poster - Agendia
AC Chemo CRC ASCO Poster | PPT
Posters ASCO 2023
Moh'd khushman on X: "Visit our posters @ASCO https://t.co/JbnosQ7USL" / X
Poster Presentation PR22 at 2022 ASCO Genitourinary Cancers Symposium | Canadian Cancer Trials Group
Presenting FLC Posters at ASCO 2023 - FibroFighters
American Society of Clinical Oncology (ASCO) 2018 – Poster | Sutro Biopharma, Inc.
ASCO Poster | PPT
GAP Study poster presented at ASCO - GI Cancer
ASCO 2013 - Poster: A randomized, phase II trial of sipuleucel-T with concurrent or sequential abiraterone acetate plus prednisone in metastatic castrate-resistant prostate cancer (mCRPC)